Search Result "CYP1A2"
Frequency of CYP1A2 Polymorphism in Beagle Dogs
Journal: Drug Metabolism Letters
Volume: 1 Issue: 2 Year: 2007 Page: 163-165
Author(s): Valerie J. Whiterock, Terrye A. Delmonte, Lester E. Hui, Tami L. Orcutt, Michael W. Sinz
Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe
Journal: Current Drug Metabolism
Volume: 13 Issue: 5 Year: 2012 Page: 667-678
Author(s): Vidya Perera,Annette S. Gross,Andrew J. McLachlan
Caffeine Induces CYP1A2 Expression in Rat Hepatocytes but not in Human Hepatocytes
Journal: Drug Metabolism Letters
Volume: 6 Issue: 2 Year: 2012 Page: 116-119
Author(s): David Vaynshteyn,Hyunyoung Jeong
In Vitro Inhibition of Rat CYP1A1 and CYP1A2 by Piceatannol, a Hydroxylated Metabolite of trans-Resveratrol
Journal: Drug Metabolism Letters
Volume: 1 Issue: 1 Year: 2007 Page: 13-16
Author(s): Thomas K. H. Chang, Jie Chen, Chia-Ting Yu
Diosmetin Induces Cell Apoptosis by Regulating CYP1A1/CYP1A2 Due to p53 Activation in HepG2 Cells
Journal: Protein & Peptide Letters
Volume: 24 Issue: 5 Year: 2017 Page: 406-412
Author(s): Bin Liu,Kaiqiao Jia,Yu Yang,Siyuan Hao,Caijie Lu,Fengming Xu,Dehui Feng,Runzhi Zhu
The Uremic Toxin Indoxyl-3-Sulfate Induces CYP1A2 In Primary Human Hepatocytes
Journal: Drug Metabolism Letters
Volume: 10 Issue: 3 Year: 2016 Page: 195-199
Author(s): Hong Liu,Rangaraj Narayanan,Matthew Hoffmann,Sekhar Surapaneni
Potential Polymorphic CYP1A2 and CYP2D6-mediated PharmacokineticInteractions between Risperidone or Olanzapine and Selected DrugsIntended to Treat COVID-19
Journal: Drug Metabolism and Bioanalysis Letters
Volume: 16 Issue: 1 Year: 2023 Page: 6-13
Author(s): Angel Tito Alvarado Yarasca
Determination of Caffeine and its Metabolites in Saliva and Urine as a Measure of CYP1A2 Metabolic Activity
Journal: Current Pharmaceutical Analysis
Volume: 12 Issue: 4 Year: 2016 Page: 325-332
Author(s): Miroslav Turjap,Ondrej Zendulka,Zdenek Glatz,Stanislav Brejcha,Ales Madr,Jan Jurica
CYP1A2*F Polymorphism Contributes at Least Partially to the Variabilityof Plasma Levels of Dehydroaripiprazole, an Active Metabolite ofAripiprazole, in Schizophrenic Patients
Journal: Drug Metabolism and Bioanalysis Letters
Volume: 17 Issue: 1 Year: 2024 Page: 7-12
Author(s):
Differences in MDR1 (C3435T), CYP2D6, and CYP1A2 Genotype Frequencies between Patients with Treatment Failure to Antipsychotics and Healthy Russian Population
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 17 Issue: 1 Year: 2020 Page: 55-63
Author(s): Tatiana Zhiganova,Radkova Eugenia,Sergeeva Tatiana,Volovnikova Viktoriia